Evestia Clinical

Executive Summary

Evestia Clinical is a global specialist Contract Research Organization (CRO) founded in 2018 and headquartered in London, UK. The company offers a full suite of clinical trial services, including project management, site management, regulatory affairs, data management, and pharmacovigilance, with a focus on complex therapeutic areas such as oncology, rare diseases, neurology, immunology, and inflammation. Positioned as an agile, expert-driven partner for biotech companies, Evestia Clinical differentiates itself through personalized support and deep therapeutic expertise, enabling clients to navigate the complexities of clinical development efficiently. Although the company is private and operates in a highly competitive CRO market, its specialization in niche, high-complexity areas provides a distinct competitive advantage. With a lean operational model and a growing reputation in the biopharma ecosystem, Evestia Clinical is well-placed to capitalize on the increasing demand for outsourced clinical services, particularly from emerging biotech firms seeking flexible and experienced partners. The company's focus on innovation and client-centricity positions it for steady growth, though its private status limits public visibility. Overall, Evestia Clinical represents a promising but early-stage player in the CRO space, with potential for expansion driven by successful client engagements and strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026Major Contract Win with Top 20 Pharma30% success
• Q4 2026Expansion into U.S. Market via New Office20% success
• Q2 2026Launch of Decentralized Trial Services40% success